Skip to main content

BSI webinar: COVID-19 vaccine conversations: effective ways of engaging with the public

This free webinar is part of the British Society for Immunology's series 'Connecting on coronavirus: the expert hub' and new public engagement campaign about COVID-19 vaccines 'Vaccine engagement starts at home'.

This session is presented by Professor Sheena Cruickshank and Dr Matt Morgan on the topic 'COVID-19 vaccine conversations: effective ways of engaging with the public​'.

Speakers: Professor Sheena Cruickshank, Professor of Public Engagement and Biomedical Sciences, University of Manchester and Dr Matt Morgan, Consultant in Intensive Care Medicine, University Hospital of Wales.

About this webinar: With COVID-19 vaccine rollout now underway, there has never been a more important time for researchers to engage with the public around vaccination by listening and addressing common questions and concerns. BSI members and the wider research community are ideally placed to be expert sources of knowledge in these dialogues. Getting started in these conversations can seem daunting but this webinar will give you the tools you need to approach them in a constructive way and generate productive interactions. 

This webinar is aimed at BSI members and other researchers who wish to increase their skills and confidence to be positive ambassadors for COVID-19 vaccination. Our speakers discussed their experiences of engaging with the public and answered questions on how to listen to and address people’s concerns on vaccines, deal with uncertainty and have constructive conversations about vaccination. 

Please note, the content of this webinar is aimed at a researcher audience on how to use their expertise to effectively engage in conversations on vaccination.


Watch more webinars in the BSI Connecting on Coronavirus series

The 'Connecting on coronavirus: the expert hub' webinar series is supported by the British Society for Immunology's official journals: ImmunologyClinical & Experimental Immunology and Immunotherapy Advances.